Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,863,795
+$1,546,788 QoQ
Shares Held
43,885
+0.8% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 223 holders
Holding Since
Jun 2022
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. HROW ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
4,273,026 | $4,871,249 |
All Filings in HROW
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,863,795 | 43,885 | Shares | Sole | 2026-08-14 | |
| 2022-06-30 | $317,007 | 43,545 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||